These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21894807)

  • 1. Prophylactic intra-aortic balloon pump reduces C-reactive protein levels and early mortality in high-risk patients undergoing percutaneous coronary intervention.
    Gu J; Hu W; Xiao H; Feng X; Song Z; Chen Y; Zhang D
    Acta Cardiol; 2011 Aug; 66(4):499-504. PubMed ID: 21894807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction.
    Cheng JM; van Leeuwen MA; de Boer SP; Wai MC; den Uil CA; Jewbali LS; van Geuns RJ; Kardys I; van Domburg RT; Boersma E; Zijlstra F; Akkerhuis KM
    Int J Cardiol; 2013 Oct; 168(4):3758-63. PubMed ID: 23830073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-aortic balloon pump improves clinical prognosis and attenuates C-reactive protein level in acute STEMI complicated by cardiogenic shock.
    Gu J; Hu W; Xiao H; Feng X; Chen Y; Zhang D
    Cardiology; 2010; 117(1):75-80. PubMed ID: 20924182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Intra-aortic Balloon Pump before versus after Primary Percutaneous Coronary Intervention in Patients with Cardiogenic Shock from ST-elevation Myocardial Infarction.
    Yuan L; Nie SP
    Chin Med J (Engl); 2016 Jun; 129(12):1400-5. PubMed ID: 27270533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
    Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention.
    Mishra S; Chu WW; Torguson R; Wolfram R; Deible R; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 Sep; 98(5):608-12. PubMed ID: 16923445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?
    Bergh N; Angerås O; Albertsson P; Dworeck C; Matejka G; Haraldsson I; Ioanes D; Libungan B; Odenstedt J; Petursson P; Ridderstråle W; Råmunddal T; Omerovic E
    Acute Card Care; 2014 Jun; 16(2):57-62. PubMed ID: 24670205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review.
    Zheng XY; Wang Y; Chen Y; Wang X; Chen L; Li J; Zheng ZG
    BMC Cardiovasc Disord; 2016 Jul; 16(1):148. PubMed ID: 27391391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonroutine Use of Intra-Aortic Balloon Pump in Cardiogenic Shock Complicating Myocardial Infarction With Successful and Unsuccessful Primary Percutaneous Coronary Intervention.
    Hawranek M; Gierlotka M; Pres D; Zembala M; Gąsior M
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1885-1893. PubMed ID: 30236362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early application of an intra-aortic balloon pump in patients with ST-segment elevation acute myocardial infarction scheduled for elective percutaneous coronary intervention.
    Li Z; Dong P; Liu X; Yang X; Wang K; Li Z; Zhao Y; Jin G; Li Z; Li C
    J Int Med Res; 2013 Jun; 41(3):754-61. PubMed ID: 23613498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.
    Perera D; Stables R; Thomas M; Booth J; Pitt M; Blackman D; de Belder A; Redwood S;
    JAMA; 2010 Aug; 304(8):867-74. PubMed ID: 20736470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.
    Minha S; Barbash IM; Dvir D; Ben-Dor I; Loh JP; Pendyala LK; Satler LF; Pichard AD; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2014 Jan; 15(1):13-7. PubMed ID: 24444472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
    Dangas GD; Kini AS; Sharma SK; Henriques JP; Claessen BE; Dixon SR; Massaro JM; Palacios I; Popma JJ; Ohman M; Stone GW; O'Neill WW
    Am J Cardiol; 2014 Jan; 113(2):222-8. PubMed ID: 24527505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutical efficacy of routine intra-aortic balloon pump support in patients with high-risk acute myocardial infarction undergoing percutaneous coronary intervention].
    Chen J; Yang XL; Zhou ZL; Li JM; Tan HB
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1927-8. PubMed ID: 18159023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shenfu Injection () inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock.
    Jin YY; Gao H; Zhang XY; Ai H; Zhu XL; Wang J
    Chin J Integr Med; 2017 Mar; 23(3):170-175. PubMed ID: 28028723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intra-aortic balloon pump on short-term clinical outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock: A "real life" single center experience.
    de la Espriella-Juan R; Valls-Serral A; Trejo-Velasco B; Berenguer-Jofresa A; Fabregat-Andrés Ó; Perdomo-Londoño D; Albiach-Montañana C; Vilar-Herrero JV; Sanmiguel-Cervera D; Rumiz-Gonzalez E; Morell-Cabedo S
    Med Intensiva; 2017 Mar; 41(2):86-93. PubMed ID: 27650459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of intra-aortic balloon pump effectiveness in high-risk percutaneous coronary interventions without cardiogenic shock: a comprehensive meta-analysis of randomised trials and observational studies.
    Romeo F; Acconcia MC; Sergi D; Romeo A; Gensini GF; Chiarotti F; Caretta Q
    Int J Cardiol; 2013 Sep; 167(5):1783-93. PubMed ID: 23295041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.